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Abstract
Objective: To investigate the suitability of blood granulocyte and monocyte sensitivity, as measured by the quantity of
different agonists required to induce CD62L shedding, for assessment of perioperative immune changes in patients
undergoing cardiac surgery with cardiopulmonary bypass.
Methods: Patients scheduled for aortocoronary bypass grafting or for valve surgery were included in this prospective
observational study. Blood samples were drawn before anesthesia induction, directly after surgery and 48 hours after
anesthesia induction. We determined the concentration of two different inflammatory stimuli – lipoteichoic acid (LTA) and
tumor necrosis factor alpha (TNF) - required to induce shedding of 50% of surface CD62L from blood granulocytes and
monocytes. In parallel monocyte surface human leukocyte antigen (HLA)-DR, and plasma interleukin (IL)-8, soluble (s)CD62L,
soluble (s)Toll-like receptor (TLR)-2 and ADAM17 quantification were used to illustrate perioperative immunomodulation.
Results: 25 patients were enrolled. Blood granulocytes and monocytes showed decreased sensitivity to the TLR 2/6 agonist
Staphylococcus aureus LTA immediately after surgery (p = 0.001 and p= 0.004 respectively). In contrast, granulocytes
(p = 0.01), but not monocytes (p = 0.057) displayed a decreased postoperative sensitivity to TNF. We confirmed the presence
of a systemic inflammatory response and a decreased immune sensitivity in the post-surgical period by measuring
significant increases in the perioperative plasma concentration of IL-8 (p#0.001) and sTLR (p = 0.004), and decreases in
monocyte HLA-DR (p,0.001), plasma sCD62L (p#0.001). In contrast, ADAM17 plasma levels did not show significant
differences over the observation period (p = 0.401).
Conclusions: Monitoring granulocyte and monocyte sensitivity using the ‘‘CD62L shedding assay’’ in the perioperative
period in cardiac surgical patients treated with the use of cardiopulmonary bypass reveals common changes in sensitivity to
TLR2/6 ligands and to TNF stimulus. Further long-term follow-up studies will address the predictive value of these
observations for clinical purposes.
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Introduction
The clinical introduction of cardiopulmonary bypass (CPB) in
1953 by John Gibbon [1] opened a novel era in cardiac surgery,
but confronted clinicians with previously unrecognized issues.
Today, it is widely accepted that (i) exposure of blood to air and
artificial surfaces in the extracorporeal circuit, (ii) ischemia-
reperfusion injury and (iii) translocation of ‘‘pathogen associated
molecular patterns’’ across the gut mucosal barrier are contrib-
uting factors to the activation of various molecular cascades
resulting in systemic inflammatory response syndrome [2]. Clinical
correlates range from mild myocardial depression or low systemic
vascular resistance to life-threatening complications such as multi-
organ failure. Besides this usually transient inflammatory response
syndrome some patients acquire nosocomial infections (periopera-
tive incidence 5% and 21% respectively [3,4]) with influence on
morbidity and mortality [4–6].
To understand the effects of CPB on the inflammatory system,
a wide spectrum of laboratory and clinical studies have been
performed. Effects of coronary artery bypass grafting performed
off-pump (OPCABG) and on-pump (CABG) have been compared
in a review [7]. This study identified a broad network of molecules
involved in CPB-induced immunomodulation, for example, tumor
necrosis factor alpha (TNF), interleukin (IL)-1, IL-6, IL-8, and IL-
10 were found to be increased in CABG patients compared to
OPCABG patients postoperatively [8–10]. Moreover, comple-
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ment activation was higher when CABG had been performed [11–
13]. However, taking into account that the involved markers reach
peak plasma levels at different clinical stages, comparisons made
on inflammatory markers alone might be misinterpreted [14,15].
For this reason it is desirable to assess perioperative immune
alterations not exclusively by measuring the concentration of
individually selected key mediators at different time points, but
also at a functional level, by assessing the sensitivity or re-
sponsiveness of inflammatory effector cells.
One method to quantify functional changes in immunity for
their relevance in differentiating patient groups makes use of
a concept previously employed to diagnose genetic defects in Toll-
like receptor (TLR) signaling in a pediatric population by assessing
cleavage of membrane-bound CD62L from granulocytes [16].
CD62L is an adhesion molecule present on the surface of blood
granulocytes, inflammatory monocytes and naı¨ve T cells. Upon
activation of these cell types, CD62L is very rapidly enzymatically
cleaved from the cell surface [17–19]. CD62L-cleavage can be
quantified per cell within whole unfractionated human blood by
loss of staining with an antibody specific to the shed portion of the
molecule. By stimulating whole blood with a dose-titration of pro-
inflammatory stimuli (TLR ligands, TNF) it is possible to calculate
ligand concentrations required to induce shedding of 50% of
surface CD62L from monocytes and granulocytes. This method
provides a quantitative measurement of granulocyte and monocyte
sensitivity that could be easily compared between patients.
The aim of this pilot study was to investigate whether sensitivity
of granulocytes and monocytes to microbial and cytokine stimuli,
as monitored by concentrations required to induce CD62L
shedding, is modulated in cardiac surgical patients in the post-
CPB period. Parallel quantification of the perioperative cytokine
response (IL-8), human leukocyte antigen (HLA)-DR expression
and the assessment of soluble plasma factors (sCD62L, sTLR-2)
and ADAM17 activity has been performed to obtain further
information on perioperative immunomodulation for comparison
with ‘‘CD62L shedding’’ results.
Materials and Methods
Patients
The study was approved by the institutional ethical review
board (approval number: 041/09) and patients were enrolled after
written informed consent. All patients underwent elective cardiac
surgery procedures with the use of CPB. The inclusion criteria
were: age $18 years and elective coronary or valve surgery. The
exclusion criteria were: active infection, active liver disease, renal
failure or steroid use. The investigation was performed as a single
center pilot prospective observational study in a university
hospital. Patients were recruited consecutively in order of their
date of surgery.
Anesthesia and Surgery
All patients were anesthetized according to the clinical routine
of the department. After premedication with lorazepam, general
anesthesia was induced with midazolam, sufentanil and etomidate,
muscular relaxation was achieved with pancuronium. Intraopera-
tively and on CPB anesthesia was maintained using a combination
of isoflurane and continuous sufentanil infusion. After admission to
postoperative intensive care a continuous infusion of propofol and
boluses of fentanyl were used until patient`s extubation. All patients
obtained 1.5 g cefuroxim preoperatively and after termination of
CPB.
Conventional extracorporeal circulation (CECC) was used for
all cases except isolated CABG surgery, which was managed using
minimized extracorporeal circulation (MECC). CECC employed
a standard circuit which consisted of tubings, a hollow-fiber
membrane oxygenator, a roller pump, an arterial filter and
a cardiotomy reservoir. The system was primed with a mixture of
crystalloid (1000 ml) and colloid (800 ml) solution. The MECC
consisted of a closed and preconnected system with a hollow-fiber
membrane oxygenator and a centrifugal pump, which was primed
with 600 ml of crystalloid solution. A neutrophil filter was not
implemented in any of the bypass systems.
Cardiac surgery was performed using standard operation
techniques. After median sternotomy a bolus of heparin was given
(CECC: 500 IU/kg; MECC 400 IU/kg) prior to cannulation of
the ascending aorta. The target activated clotting time (ACTkaolin)
was .480 seconds (ACT PlusTM, Medtronic Ltd., MN, USA).
Furthermore, all patients received a bolus of tranexamic acid
(30 mg/kg) followed by a continuous infusion (15 mg/kg/h) until
the end of sternal closure. Once the CPB was initiated the aorta
was cross-clamped and antegrade low-volume crystalloid cardio-
plegia (Cardioplexol, Laboratorium Dr. G. Bichsel AG, Inter-
laken, Switzerland) followed by high-potassium cold blood
cardioplegia was delivered into the coronary arteries. After
weaning from CPB heparin was reversed with protamin in the
ratio 1:1 with regard to the initial heparin bolus. Finally, all
patients were transferred to the intensive care unit.
Blood Sampling and Preparation
Blood sampling of 5 ml whole blood was performed at three
time points in a heparinized and a citrate collection tube which
were immediately transported to the laboratory. We chose citrate
blood only for the CD62L-shedding assay as it lets us take into
account the effects of procoagulatory signaling which is critical in
innate immune activation. Furthermore, with the use of citrate,
which is a weak Ca2+ chelator, we reduced the removal of calcium
minimizing interactions with TLR signaling cascade.
The first sample (serving as control) was drawn after the radial
arterial cannulation before induction of anesthesia. The second, at
the beginning of the sternal wiring. The third, 48 hours after the
first blood sampling.
CD62L-shedding Assay
Twenty-five ml citrate whole blood was stimulated with 25 ml of
six 10-fold dose-titrations starting at 10 mg/ml (LTA, Invivogen,
San Diego, USA), 20 ng/ml (TNF, R&D). After 45 minutes
incubation at 37uC/5% CO2, cells were washed in PBS/BSA 1%
and stained with 25 ml PBS/BSA 1% containing APC-anti-human
CD33 (allowing identification of both granulocytes and monocytes in
combination with side-scatter measurement, and remaining stable during
stimulation [20]) and FITC-anti-human CD62L antibodies (Biole-
gend, San Diego, USA) for 15 minutes. Red blood cells were lysed
in 200 ml FACS Lysis solution (BD Biosciences, San Diego, USA)
and acquired on a FACSArray SORP (BD Biosciences, San
Diego, USA). Blood monocytes and granulocytes were distin-
guished on the basis of CD33 expression and side scatter using
FlowJo Software (Tree Star Inc., Ashland, USA). Median FITC
fluorescence intensity is computed for each sample’s granulocytes
and monocytes and plotted against dilution factor to enable
parallel analysis of multiple agonists. Four-parameter curves are
fitted using non-linear regression and LogEC50 values were
extracted, corresponding to the dilution factor giving 50%
granulocyte or monocyte CD62L-shedding. The corresponding
ligand concentration was calculated from the dilution factor and
plotted for each ligand.
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IL-8 ELISA
IL-8 levels in plasma were quantified using the BD OptEIAtm
human IL-8 ELISA kit II (BD Bioscience, San Jose, CA, USA)
according to the manufacturer’s instructions. All samples were
diluted 1:3 before loading onto the plate and measured in
duplicates, as were all standards and blanks. The detection range
(standard curve) was 3.1 to 200 pg/ml. Intra- and interassay
variation ranged from 4 to 5.5 and 3.2 to 3.4%CV respectively
(information provided by manufacturer).
HLA-DR
Fifty microlitre heparinized whole blood were stained with
20 ml QuantibriteTM anti-human-HLA-DR PE(phycoerythrin)/
anti-monocyte PerCP (peridinin chlorophyll protein)-Cy5.5 (anti-
human-CD14 and anti-human-CD64) (BD Biosciences, San
Diego, USA) at room temperature in the dark, for 25 minutes.
Red blood cells were subsequently lysed with FACS lysing
solution (BD Biosciences, San Diego, USA) for five to ten
minutes and washed twice with phosphate buffered saline
solution (Sigma-Aldrich, St. Louis, USA) and fixed with 400 ml
4% paraformaldehyde. One unstained sample was treated in the
same manner. Fluorescence intensity of the samples was
measured in duplicates on an LSR II Cytometer (BD
Biosciences, San Diego, USA) using the software CellQuest
(BD Biosciences, San Diego, USA). 500–1000 monocyte events
were recorded. For quantification of the signal QuantibriteTM
PE beads (BD Biosciences, San Diego, USA) were acquired with
each measurement. FACS data was analyzed with FlowJo v. 7.5
(Tree Star Inc., Ashland, USA) by gating for CD14 and CD64
positive cells (monocytes). The HLA-DR PE channel was
calibrated using the data from the PE Beads, which allows
the correlation of fluorescence intensity to the mean number of
PE molecules per cell. The results were recorded as the
geometric mean of the calibrated PE channel fluorescence
intensity of each sample.
sCD62L (sL-selectin) ELISA
Plasma samples were diluted 1:200 and the sL-selectin
concentration was measured with a human sL-selectin platinum
ELISA kit (eBioscience, Vienna, Austria) according to the
manufacturer`s instructions. All standards, samples and controls
were measured in duplicates. The detection range (standard curve)
was 0.4 to 25 ng/ml. Intra- and interassay variation was 3.7 and
4.2%CV respectively, as declared by the manufacturer.
sTLR-2
sTLR-2 plasma concentrations were detected using a human
TLR-2 ELISA kit (Cusabio, Wuhan, China). Samples were diluted
1:3 and measured together with standards and blanks in duplicate.
The detection range (standard curve) was 0.312–20 ng/ml, intra-
and interassay variation was given as 8 and 10%CV by the
manufacturer.
ADAM 17 (TACE) ELISA
All samples were measured undiluted and in duplicates using
a TACE human ELISA kit (Abcam, Cambridge, UK) according
to the manufacturer’s instructions. The detection range (standard
curve) was 78.15–5000 pg/ml, intra- and interassay variation was
given as 10 and 12%CV by the manufacturer.
Absorption was read at 450 nm for all measurements with an
Elx800 Microplate reader (Biotek Instruments) and evaluated with
Gen5 Software (v1.09). The blank absorption value was subtracted
from all standards and samples. These values were then used to
draw a standard curve from which the concentrations of the
samples were derived. A coefficient of variation below 20% was
considered acceptable.
Statistical Analysis
Categorical data are given as integral number, percentage or
mean and standard deviation. For comparisons between groups
or repeated measures, data normality was tested by the Shapiro-
Wilk normality test. Non-parametric testing was performed by
Friedman Repeated Measures ANOVA on ranks with the
Tukey post-hoc test for all pairwise multiple comparisons
procedures. These data are presented as medians with
interquartile ranges. The Pearson product moment correlation
has been used for analyses between the tests quantifying
immune sensitivity. For all statistical results a p-value of
,0.05 was considered as significant. All statistical analyses were
performed using the SigmaPlot software version 12.0 (Systat
Software Inc., San Jose, CA, USA).
Results
Demographics of the Study Population and Procedure
Characteristics
Twenty-five consecutive patients were included in the study.
Fourteen patients underwent CABG surgery, 9 patients underwent
valve surgery (VS) and two patients received combined surgery
(CABG and VS). Eleven patients were treated using CECC
whereas fourteen patients underwent perfusion using MECC
(TABLE 1.).
CD62L Shedding of Granulocytes and Monocytes after
Stimulation with LTA
A ten-fold increase in the concentration of LTA from the gram
positive bacterium Staphylococcus aureus required to activate both
granulocytes (p = 0.001) and monocytes (p = 0.004) was apparent
immediately post-surgery in a large fraction of patients (FIG-
URE 1A and B). In the majority of patients, sensitivity is recovered
48 hours post-surgery (TABLE 2.).
CD62L Shedding of Granulocytes and Monocytes after
Stimulation with TNF
We observed a roughly 10-fold decreased sensitivity of
granulocytes to TNF stimulation immediately post-surgery, as
revealed by a 10-fold increased concentration of TNF required to
produce 50% loss of CD62L-staining on the cell surface (p = 0.01,
TABLE 2.). In contrast to changes in LTA sensitivity, the change
in TNF sensitivity was not clearly observed in monocytes
stimulated in the same blood samples (p = 0.057, FIGURE 2A
and B). The change in TNF sensitivity was clearly heterogeneous
between patients, i.e. approximately 50% of patients showed this
change in sensitivity, whereas others maintained sensitivity
throughout the operation period.
Flow Cytometric Measurement of Monocytic HLA-DR
Expression
In seventeen of the twenty-five patients analyzed for granulocyte
and monocyte sensitivity, HLA-DR surface expression was
quantified in CD14 and CD64 double-positive monocytic cells.
This analysis showed a perioperative decrease in median density of
surface HLA-DR on monocytes in patients treated with CPB
(p = 0.001, TABLE 2., FIGURE 3).
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Association of HLA-DR Expression Data with CD62L
Shedding to LTA and TNF
Regression analyses within our sample detected no significant
statistical associations between the three sensitivity measures
shown to change in the perioperative period (LTA/TNF:
r = 0.10, p = 0.40; LTA/HLA-DR: r =20.21, p = 0.078; TNF/
HLA-DR: r =20.13, p = 0.28).
Perioperative Plasma Levels of IL-8, sCD62L, sTLR-2 and
ADAM17
These analyses were performed in a subset of patients (18/25)
due to limited sample volume.
IL-8 plasma levels significantly increased after surgery
(p#0.001) and after 48 hours (p#0.001) when compared with
the preoperative values (FIGURE 4), whereas sCD62L plasma
levels significantly decreased after surgery (p#0.001) and after 48
hours (p#0.001) in comparison with the preoperative levels
(FIGURE 5). sTLR-2 showed a significant decrease between the
sampling points ‘‘after surgery’’ and ‘‘48 hours.’’ (p = 0.004,
TABLE 3). The analysis of ADAM17 activity did not show
significant differences between the different time points (p = 0.401),
but a trend of the medians was apparent towards higher values
postoperatively and after 48 hours (TABLE 3).
CD62L Shedding between Different Cardiopulmonary
bypass Methods and Surgical Procedures
Changes in sensitivity of granulocytes and monocytes to LTA
stimulation and granulocytes to TNF stimulation were observed
similarly in patients undergoing both CECC and MECC.
Additionally, no difference was seen between patients undergoing
CABG or VS (TABLE 4).
Discussion
This pilot study investigated perioperative immunomodulation
in cardiac surgery patients treated with CPB, using a novel CD62L
shedding assay. In contrast to methods quantifying cytokine levels
in serum or cell surface phenotypes, the CD62L-shedding assay
allowed direct quantification of the immunologically relevant
function of blood granulocytes and monocytes. Moreover, the
comparison of our observations to established methods of
quantifying immune change indicate that monitoring of perio-
perative immunomodulation by the CD62L shedding assay could
contribute to a more complete interpretation of perioperative
immune response by assessing the sensitivity of inflammatory
effector cells to microbial stimulation on a functional level.
The shedding of the extracellular domain of the CD62L
receptor is detectable minutes after cell activation [17–19].
Previous studies have measured CD62L shedding by ELISA, but
such methods either cannot identify the cellular source of shed
CD62L if carried out on whole blood, or require lengthy cell
purification [21]. Instead, we have made use of a technique
developed by Slack et al. that uses the cleavage of the membrane
bound CD62L molecules as a surrogate parameter for early cell
activation (manuscript in preparation). In contrast to previous
studies examining the diagnostic value of changes in CD62L
expression levels during various disease states [11,21–23], our data
is entirely independent of absolute CD62L-expression levels
[24,25]. In this regard the CD62L shedding assay is a novel
method to monitor neutrophil responsiveness using a range of
agonist concentrations from sub-saturating to fully saturating and
fitting 4-parameter curves to calculate a sensitivity independently
of the absolute receptor load on the cell surface. This avoids
potential loss of information when ‘‘close-to-saturating’’ doses are
applied, potentially revealing no altered absolute CD62L level
despite a change in sensitivity. Therefore, our method provides
different information regarding cell functionality from the in-
formation gleaned from the absolute receptor number per cell
directly ex vivo.
As showed by Pillay et al. the identification of human
neutrophil subsets can further contribute to a better understanding
of mechanisms underlying immune changes following endotoxin
challenge or severe injury [26]. As our LC50 calculations provide
an average sensitivity to stimulation over all CD33-intermediate,
side-scatter high cells, any augmentation of a neutrophil subset
falling within this definition would almost certainly contribute to
an altered LC50 (since we averaged over all neutrophils) and may
be part of the mechanism underlying altered sensitivity. A further
contributor to the mechanism of altered myeloid cell sensitivity
could also be in vivo activation of myeloid cells by the surgical
procedure, possibly including some in vivo shedding of CD62L. As
the LC50 calculation relies upon the difference in CD62L surface
staining between unstimulated cells and those cells stimulated with
a saturating dose of agonist, a lower ‘‘unstimulated’’ surface
CD62L level may indeed affect the LC50, but most likely less than
Table 1. Basic clinical and procedural characteristics
according to the type of surgery or the type of ECC.
Type of surgery All CABG VS CABG+VS p*
Patients 25 14 9 2
Age, years 67612 71610 63612 54619 ns
Female, sex 12 (48) 6 (43) 5 (55) 1 (50) ns
Diabetes 9 (36) 7 (50) 2 (22) 0 (0) ns
EuroScore
(additive)
663 562 664 667 ns
Duration of
surgery, min
230658 228641 232677 2356106 ns
ECC time, min 83642 60614 112651 105649 0.003
LOS, days 9.762.7 9.462 10.363.8 960 ns
In-hospital
mortality
0 (0) 0 (0) 0 (0) 0 (0) ns
Type of ECC CECC MECC p*
Patients 11 14
Age, years 61612 71610 ns
Female, sex 6 (54) 6 (43) ns
Diabetes 2 (18) 7 (50) ns
EuroScore
(additive)
764 562 ns
Duration of
surgery, min
233677 228641 ns
ECC time, min 111648 60614 ,0.001
LOS, days 1063 962 ns
In-hospital
mortality
0 (0) 0 (0) ns
Values are presented as total number of patients (percent) or mean 6 standard
deviation.
*p- values .0.05 considered as non significant (ns).
Definitions: CABG, coronary artery bypass grafting; VS, valve surgery; ECC,
extracorporeal circulation; CECC, conventional extracorporeal circulation; MECC,
minimized extracorporeal circulation; LOS, length of postoperative hospital
stay.
doi:10.1371/journal.pone.0053045.t001
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signaling changes induced by the pre-activation itself. Interesting-
ly, elevated soluble TLR2 levels in plasma correspond to decreased
sensitivity to the TLR2/6 agonist LTA, suggesting that an
important modulator of sensitivity to TLR2 agonists post-surgery
may be secretion of the soluble receptor form. However, due to
limited marker usage, a full investigation into underlying
mechanisms would require a follow-up study to elucidate.
Our presented method thus evaluated the sensitivity of
monocytes and granulocytes to an ex vivo microbial stimulation
by quantifying the LC50 value, always defined as the concentra-
tion of agonist applied ex vivo that elicits a 50% drop in CD62L
MFI. A variety of underlying mechanisms, including presence of
soluble antagonists, cell activation and appearance of novel
subsets, may alter the observed LC50, making this potentially
a useful read-out of a broad range of immune changes.
Given the preliminary nature of this pilot study and the size and
diversity of the cohort studied, it is surprising that such marked
differences in granulocyte and monocyte sensitivity could be
observed immediately post-surgery. However, some clues to the
relevance may come from examining why changes in responsive-
ness are observed specifically to LTA and TNF. Explanations
could either involve modulation of receptor and signaling
component expression in pre-existing cells by the blood milieu
during surgery, or release of less mature granulocytes and
monocytes into the circulation from bone marrow stores which
may have a slightly different expression profile of receptors and
signaling components for the TLR2/6 and TNF receptor
pathways.
A well-established phenomenon in immunobiology is that of
endotoxin tolerance, i.e. exposure to Lipopolysaccharide from
gram negative Escherichia coli is followed by suppressed responsive-
ness to stimulation with the same agonist [27]. Diacylated
lipopeptides that form the ligands for the TLR2/6 receptor
complex are common major components of the cell walls of gram
positive bacteria. Hence, it may be relevant to note that Hamers
and colleagues found live culturable bacteria in around 1% of the
priming circuit cultures and 5.6% of the CBP blood cultures [28].
About 80% of the positive priming circuit cultures and about 70%
of the CBP blood cultures were infected with gram positive cocci.
Such bacterial species are very common skin commensal bacteria
that the patient may be exposed to during these long surgical
procedures. However, for this to explain our data, the recovery
rate of live bacteria would have to massively underestimate the
actual exposure as almost all of the 25 patients examined showed
loss of sensitivity to TLR2/6 ligands compare to a predicted 1–6%
contamination rate of patient blood. An alternative explanation is
suggested by the observed post-surgical myelocytosis in patient
blood. The bone marrow harbors a massive store of blood
granulocytes and monocytes, with only a small percentage of these
cells present in the circulation [29]. Activation of damage-sensing
pathways by the surgical procedure and blood contact to foreign
surfaces is a strong stimulus for bone marrow myeloid pool
mobilization, releasing a large number of ‘‘fresh’’ granulocytes and
Figure 1. Granulocyte and monocyte sensitivity by lipoteichoic acid stimulation. 1A and B. Granulocyte (A) and monocyte (B) sensitivity by
lipoteichoic acid (LTA) stimulation was modified in the perioperative period. The figure shows the median values (long orange line) with interquartile
ranges (short purple lines) at the different sampling points (*p,0.05 compared with the previous sampling point). Each black line represents data
from an individual patient. The CD62L shedding assay was quantified by measuring the ligand concentration (LC)50. In the study setting LC50
represented the concentration of the stimulant which caused the shedding of 50% of the CD62L molecules from the surface of the cell type of
interest. Thus, in the presented figure, higher values of LC50 represent a loss of sensitivity to stimulation with this particular agonist.
doi:10.1371/journal.pone.0053045.g001
Table 2. Granulocyte and monocyte activation with different
inflammatory stimuli.
before
surgery after surgery 48 hrs. p*
LTA
granulocytes 1225 [999;2364] 9602
[1242;10000]
1177 [916;2748] 0.001
monocytes 191 [112;508] 780 [113;1535] 97 [74;164] 0.004
TNF
granulocytes 2 [2;9] 20.0 [2;28.5] 3 [2;5] 0.01
monocytes 1 [0;2] 1 [1;3] 2 [1;3] 0.057
HLA
CD14/CD64 19204
[12740;24268]
9694
7907;11039]
6969
[4303;11976]
0.001
Values are presented as median and interquartile ranges [25th;75th].
*p- values .0.05 considered as non significant.
Definitions: LTA, lipoteichoic acid; TNF, tumor necrosis factor; HLA, human
lymphocyte antigen; CD14/64, cluster of differentiation 14/64 monocytes.
doi:10.1371/journal.pone.0053045.t002
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monocytes into the peripheral circulation. It is highly possible that
newly released cells require several hours to develop the full
repertoire of signaling receptors and transducers present on fully
mature granulocytes and monocytes, or that the results of a final
maturation step in the ‘‘activated’’ surgical milieu produces
a different mature state to that developed under resting conditions.
Thus, altered sensitivity to LTA and TNF is likely to be the result
of activator signals received by the patient immune system, either
due to exposure to contaminating gram positive bacteria, or
directly due to the surgical procedure. Likewise, the severity of
deviation in sensitivity may well be relevant during the post-
operative period when infections with gram-positive bacteria such
as Staphylococcus aureus are a major concern. Unfortunately, our
small study allows no pertinent conclusions due to small sample
Figure 2. Granulocyte and monocyte sensitivity by tumor necrosis factor alpha stimulation. 2A and B. Granulocyte (A) and monocyte (B)
sensitivity by tumor necrosis factor (TNF) stimulation. The figure shows the median values (long orange line) with interquartile ranges (short purple
lines) at the different sampling points (*p,0.05 compared with the previous sampling point). Each black line represents data from an individual
patient. The CD62L shedding assay was quantified by measuring the ligand concentration (LC)50. In the study setting LC50 represented the
concentration of the stimulant which caused the shedding of 50% of the CD62L molecules from the surface of the cell type of interest. Thus, in the
presented figure, higher values of LC50 represent a loss of sensitivity to stimulation with this particular agonist.
doi:10.1371/journal.pone.0053045.g002
Figure 3. Monocytic HLA-DR expression. HLA-DR molecules per CD14 and CD64 positive cell calculated perioperatively. The figure shows the
median values (long orange line) with interquartile ranges (short purple lines) at the different sampling points (*p,0.05 compared with the previous
sampling point; 1*p,0.05 compared with the first sampling point). Each black line represents data from an individual patient.
doi:10.1371/journal.pone.0053045.g003
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size, diversity of surgical procedures and perfusion techniques.
Moreover, our pilot feasibility study was not designed in this
direction.
To validate the presented CD62L shedding-assay and to gain
a more complete insight into the perioperative inflammatory state,
in particular the change in neutrophil response, the application of
established methods and the analysis of multiple markers would be
desirable as proposed by Pillay [24]. For this reason the
perioperative course of IL-8, HLA-DR, sCD62L, sTLR-2 and
ADAM17 has been investigated additionally to CD62L shedding
assay.
The measured IL-8 results are in accordance with other groups
[30–32] and confirm a proinflammatory response post-CPB in our
cohort. However, the IL-8 course is more of general character
being affected by a great variability of intraoperative factors and
does not allow conclusions about the functional immune status in
the patients. Likewise, our HLA-DR results confirmed previously
observed decrease in expression levels post-CPB. Moreover the
results agree with published absolute molecule numbers per cell
preoperatively, in the post-surgical period and after 48 hours [33].
The lack of any mutual association of HLA-DR expression data
and sensitivity to LTA or TNF in our cohort may well indicate
that these three responses represent independent aspects of post-
surgical immune function. At this stage, however, we cannot
exclude that this is simply due to under-powering of our study.
The perioperative course of sCD62L plasma concentration as
a further surrogate marker of in vivo neutrophil activation was in
line with other investigations [34–35] The reduced levels of
sCD62L were presumed to reflect the reduced CD62L shedding in
the postoperative period and after 48 hours, which is highly
suggestive of a (temporary) decrease of circulating neutrophil
activity [36] in keeping with our observations for decreased
neutrophil sensitivity to TNF and lipoteichoic acid.
The sTLR-2 increase after the surgical procedure was
accompanied by an increase of the LC50 values for LTA, as
determined with the ‘‘CD62L-shedding assay’’ reflecting de-
creased granulocyte and monocyte reactivity. Also, at the time
point ‘‘48 hrs.’’ the decreased sTLR-2 values were accompanied
by decreased LC50 values showing normalization of immune
reactivity. Thus it is likely that the previously assumed role of
sTLR-2 as a negative regulator of TLR-2 mediated signaling
pathways [37] is a major contributor to the altered responsiveness
to LTA observed post-surgery.
The analysis of ADAM17 confirms perioperative inflammation
as measured by different markers in this study. However, we were
not able to detect a direct correlation between ADAM17 and
CD62L shedding pattern (ADAM17 levels remained still high after
48 hrs.) This result maybe reflects previous findings on ADAM17
regulating CD64L`s surface density (which we did not directly
Table 3. sTLR-2 and ADAM17 course during the
observational period.
before
surgery after surgery 48 hrs. p*
sTLR-2 1.4 (1.2;2.4) 2.5 (1.9;3.6) 0.8 (0.6;1.2) 0.004
ADAM17 436 (227;849) 574 (274;1769) 761 (402;1145) 0.401
Values are presented as median and interquartile ranges (25th;75 th).
*p- values .0.05 considered as non significant.
Definitions: sTLR-2, soluble form of Toll-like receptor-2; ADAM17, ADAM
metalloproteinase domain 17 (also called TACE – tumor necrosis factor-a-
converting enzyme).
doi:10.1371/journal.pone.0053045.t003
Figure 4. Perioperative plasma levels of IL-8. IL-8 concentration (pg/ml) in the perioperative course. The figure shows the median values (long
orange line) with interquartile ranges (short purple lines) at the different sampling points (*p,0.05 compared with the previous sampling point;
1*p,0.05 compared with the first sampling point). Each black line represents data from an individual patient.
doi:10.1371/journal.pone.0053045.g004
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quantify) but not the cleavage (which was the major read-out used
to determine LC50 measurements of sensitivity) [38].
In conclusion, monitoring granulocyte and monocyte sensitivity
using the ‘‘CD62L shedding assay’’ in the perioperative period in
cardiac surgical patients undergoing cardiopulmonary bypass
reveals common changes in sensitivity to TLR2/6 ligands and to
TNF stimulus. Our data support the further investigation of this
novel assay to provide complementary information to currently
established methods for the interpretation of perioperative
immune responsiveness.
Further long-term follow-up studies with larger and more
homogenous cohorts will help to address the predictive value of
these observations for clinical purposes and to elucidate whether
the described changes relate to the exact surgical procedure or
inter-individual variation.
Figure 5. Perioperative plasma levels of sCD62L. sCD62L (ng/ml) concentration in the perioperative course. The figure shows the median
values (long orange line) with interquartile ranges (short purple lines) at the different sampling points (*p,0.05 compared with the previous
sampling point; 1*p,0.05 compared with the first sampling point). Each black line represents data from an individual patient.
doi:10.1371/journal.pone.0053045.g005
Table 4. Granulocyte and monocyte stimulation in different bypass techniques and surgeries.
CECC MECC p CABG VS p
LTA
before
surgery
granulocytes
monocytes
1770 [966;2564]
264 [119;494]
1112 [946;2342]
174 [90;575]
ns
ns
1112 [859;2133]
319 [93;634]
1770 [1087;7319]
191 [117;379]
ns
ns
after
surgery
granulocytes
monocytes
10000 [1242;12951]
804 [103;2000]
6209 [1211;10000]
769 [185;1429]
ns
ns
10000 [1526;10000]
870 [355;1918]
9205 [1195;22629]
290 [98;1397]
ns
ns
48 hrs. granulocytes
monocytes
1291 [986;2748]
111 [74;175]
1086 [830;3758]
96 [59;109]
ns
ns
1086 [850;2973]
96 [63;110]
1618 [1013;5220]
116 [74;192]
ns
ns
TNF
before
surgery
granulocytes
monocytes
2 [2;8]
1 [0.5;2]
3 [2;12]
1 [0;2]
ns
ns
3 [2;10]
1 [0;1.5]
2 [2;9]
1[0;3]
ns
ns
after
surgery
granulocytes
monocytes
20 [2;36]
2 [1;4]
12 [2;25]
1 [0;4]
ns
ns
4 [2;22]
1 [0;3]
28 [2;50]
2 [1.5;4]
ns
ns
48 hrs. granulocytes
monocytes
3 [2;5]
2 [1;2]
3.6 [1;6]
2 [1;7]
ns
ns
3 [1;5]
2 [1;6]
3 [2;4]
2[1;2]
ns
ns
Values are presented as median and interquartile ranges [25th;75th]. ns = non significant difference.
Definitions: CECC, conventional extracorporeal circulation; MECC, minimized extracorporeal circulation; CABG, coronary artery bypass grafting; VS, valve surgery; LTA,
lipoteichoic acid; TNF, tumor necrosis factor alpha.
doi:10.1371/journal.pone.0053045.t004
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Limitations of the Study
This study has several limitations. The main limitation is
probably its small sample size with a heterogeneous patient
population undergoing different cardiac surgical operations using
different cardiopulmonary bypass techniques. As a consequence,
the study cannot draw pertinent conclusions on the diagnostic
relevance of our observations. However, the current study was
intended to investigate the feasibility of CD62L-shedding mea-
surements in assessment of patients during surgical procedures.
Follow-up studies will now be able to take this observation of
feasibility to evaluate the effect of cardiac surgery on the immune
responsiveness and to discriminate differences in the peri-operative
immune sensitivity between variable perioperative conditions.
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